J.F. Cadranel

1.5k total citations
33 papers, 1.0k citations indexed

About

J.F. Cadranel is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, J.F. Cadranel has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Hepatology and 7 papers in Surgery. Recurrent topics in J.F. Cadranel's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (7 papers). J.F. Cadranel is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (7 papers). J.F. Cadranel collaborates with scholars based in France, Switzerland and United Kingdom. J.F. Cadranel's co-authors include Thierry Poynard, Vlad Ratziu, M. Munteanu, Frédéric Charlotte, Mohamed Tahiri, L. Bonyhay, Djamila Messous, Julien Massard, Brigitte Le Bail and Françoise Imbert‐Bismut and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and European Respiratory Journal.

In The Last Decade

J.F. Cadranel

29 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.F. Cadranel France 10 786 485 238 234 118 33 1.0k
Kaushal Madan India 18 592 0.8× 544 1.1× 160 0.7× 559 2.4× 95 0.8× 32 1.3k
Anjali Amarapurkar India 17 590 0.8× 292 0.6× 220 0.9× 366 1.6× 80 0.7× 61 1.1k
E Fassio Argentina 21 1.2k 1.5× 883 1.8× 333 1.4× 336 1.4× 35 0.3× 45 1.5k
Ira Willner United States 16 832 1.1× 706 1.5× 235 1.0× 457 2.0× 198 1.7× 31 1.4k
Nikhil D Patel India 18 915 1.2× 525 1.1× 402 1.7× 442 1.9× 31 0.3× 40 1.3k
Philipp Kasper Germany 12 697 0.9× 182 0.4× 283 1.2× 144 0.6× 53 0.4× 63 1.0k
Fernando Casafont Spain 24 1.4k 1.8× 1.2k 2.4× 76 0.3× 635 2.7× 62 0.5× 72 2.1k
Rosa Martín‐Mateos Spain 14 513 0.7× 413 0.9× 64 0.3× 228 1.0× 65 0.6× 39 923
Willem Pieter Brouwer Netherlands 20 1.1k 1.4× 836 1.7× 131 0.6× 87 0.4× 53 0.4× 62 1.3k
Ohad Etzion Israel 16 477 0.6× 342 0.7× 65 0.3× 247 1.1× 46 0.4× 69 854

Countries citing papers authored by J.F. Cadranel

Since Specialization
Citations

This map shows the geographic impact of J.F. Cadranel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.F. Cadranel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.F. Cadranel more than expected).

Fields of papers citing papers by J.F. Cadranel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.F. Cadranel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.F. Cadranel. The network helps show where J.F. Cadranel may publish in the future.

Co-authorship network of co-authors of J.F. Cadranel

This figure shows the co-authorship network connecting the top 25 collaborators of J.F. Cadranel. A scholar is included among the top collaborators of J.F. Cadranel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.F. Cadranel. J.F. Cadranel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allaire, Manon, Anna Sessa, J.F. Cadranel, & Pascal Lebray. (2021). Reply to: “Combined heart-liver transplantation for congestive hepatopathy with bridging fibrosis: Is it warranted?”. JHEP Reports. 3(4). 100327–100327. 1 indexed citations
2.
Baldacci, Simon, Martin Figeac, Martine Antoine, et al.. (2019). P2.14-53 High MET Overexpression Does Not Predict the Presence of MET Exon 14 Splice Mutations in NSCLC: Results from the IFCT Predict.amm Study. Journal of Thoracic Oncology. 14(10). S851–S851. 2 indexed citations
3.
Cadranel, J.F.. (2011). Élévation chronique des transaminases : hypertransaminasémie chronique. EMC - Traité de médecine AKOS. 6(1). 1–8.
4.
Morin, Thierry, Alexandre Pariente, Pierre Lahmek, et al.. (2010). Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort. European Journal of Gastroenterology & Hepatology. 22(2). 157–166. 19 indexed citations
5.
Cadranel, J.F., Martine Antoine, & Marie Wislez. (2009). Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar carcinoma features: a clinico-pathological spectrum. PubMed. 24(8 Pt 2). 445–452. 1 indexed citations
6.
Nguyen-Khac, Éric, Isabelle Ollivier, Thomas Aparicio, et al.. (2009). Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multicenter French study. Cancer Biology & Therapy. 8(21). 2033–2039. 8 indexed citations
7.
Cadranel, J.F. & Thierry Thévenot. (2008). Une hypertransaminasémie chronique. Gastroentérologie Clinique et Biologique. 32(5). S205–S209. 1 indexed citations
8.
Poynard, Thierry, Vlad Ratziu, Frédéric Charlotte, et al.. (2006). Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterology. 6(1). 34–34. 240 indexed citations
9.
Ratziu, Vlad, Julien Massard, Frédéric Charlotte, et al.. (2006). Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterology. 6(1). 6–6. 380 indexed citations
10.
Picard, C., et al.. (2006). [Immune mediated intra-alveolar haemorrhage in the adult].. PubMed. 23(1 Suppl). 3S61–73. 1 indexed citations
11.
Thévenot, Thierry, Jacques Denis, Vincent Jouannaud, et al.. (2006). CA 70-Prévalence de la maladie coeliaque au cours de l’hépatite chronique virale C : résultat final d’une étude prospective multicentrique. Gastroentérologie Clinique et Biologique. 30(8-9). 1084–1084. 1 indexed citations
12.
Halimi, Chantal, Philippe Bonnard, Brigitte Bernard, et al.. (2002). Effect of terlipressin (Glypressin®) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study*. European Journal of Gastroenterology & Hepatology. 14(2). 153–158. 85 indexed citations
13.
Devergie, Bruno, et al.. (2000). Blindness following gastrointestinal haemorrhage. European Journal of Gastroenterology & Hepatology. 12(12). 1339–1341. 3 indexed citations
14.
Gondouin, Anne, E Ranfaing, J.F. Cadranel, et al.. (1996). Exogenous lipid pneumonia: a retrospective multicentre study of 44 cases in France. European Respiratory Journal. 9(7). 1463–1469. 154 indexed citations
15.
Martino, Vincent Di, F. Lunel, J.F. Cadranel, et al.. (1996). Long‐term effects of interferon‐α in five HIV‐positive patients with chronic hepatitis B. Journal of Viral Hepatitis. 3(5). 253–260. 17 indexed citations
16.
Cadranel, J.F., Patrice Nordmann, Hervé Hagège, et al.. (1993). Grand mal seizures as a complication of treatment with pefloxacin in patients with cirrhosis. A report of three cases. Journal of Hepatology. 19(3). 383–384. 6 indexed citations
17.
Aractingi, S., et al.. (1993). Sarcoidosis Associated with Leucocytoclastic Vasculitis. Dermatology. 187(1). 50–53. 13 indexed citations
18.
Lunel, F., J.F. Cadranel, J. Moussalli, et al.. (1991). High prevalence of viral B hepatitis after heart transplantation. Journal of Hepatology. 13. S140–S140. 1 indexed citations
19.
Oksenhendler, E, et al.. (1990). Zidovudine for HIV-related myelopathy.. PubMed. 88(5N). 65N–66N. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaushal Madan Breakdown of academic impact, for papers by Anjali Amarapurkar Breakdown of academic impact, for papers by E Fassio Breakdown of academic impact, for papers by Ira Willner Breakdown of academic impact, for papers by Nikhil D Patel Breakdown of academic impact, for papers by Philipp Kasper Breakdown of academic impact, for papers by Fernando Casafont Breakdown of academic impact, for papers by Rosa Martín‐Mateos Breakdown of academic impact, for papers by Willem Pieter Brouwer Breakdown of academic impact, for papers by Ohad Etzion
Rankless by CCL
2026